ODDITY Tech Ltd.(ODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ODD ODDITY Tech Ltd.

Market Closed 11-13 16:00:00 EST

17.63

+0.90

+5.38%

盘后17.63

+0.000.00%

19:30 EST

High18.20	Low16.60	Vol1.07M
Open16.61	D1 Closing16.73	Amplitude9.56%
Mkt Cap813.18M	Tradable Cap503.97M	Total Shares46.12M
T/O18.92M	T/O Rate3.75%	Tradable Shares28.59M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ODD","market":"US","secType":"STK","nameCN":"ODDITY Tech Ltd.","latestPrice":17.63,"timestamp":1794603600000,"preClose":16.73,"halted":0,"volume":1073364,"hourTrading":{"tag":"盘后","latestPrice":17.63,"preClose":17.63,"latestTime":"19:30 EST","volume":12368,"amount":218047.76,"timestamp":1794616202128,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.05379557680812902,"floatShares":28586000,"shares":46124600,"eps":0.2383,"marketStatus":"Market Closed","change":0.9,"latestTime":"11-13 16:00:00 EST","open":16.61,"high":18.2,"low":16.6,"amount":18924868.168403998,"amplitude":0.095637,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.2383,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"listingDate":1689739200000,"exchange":"NASDAQ","adjPreClose":16.73,"preHourTrading":{"tag":"盘前","latestPrice":16.72,"preClose":16.73,"latestTime":"09:03 EST","volume":952,"amount":15840.11856,"timestamp":1794578616971,"change":-0.01,"changeRate":-0.000598,"amplitude":0.019588},"postHourTrading":{"tag":"盘后","latestPrice":17.63,"preClose":17.63,"latestTime":"19:30 EST","volume":12368,"amount":218047.76,"timestamp":1794616202128,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7296481896409596,"impliedVol":0.8612,"impliedVolPercentile":0.3028},"requestUrl":"/m/hq/s/ODD","defaultTab":"news","newsList":[{"id":"2683154883","title":"Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2683154883","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683154883?lang=en_us&edition=fundamental","pubTime":"2026-11-13 05:30","pubTimestamp":1794519000,"startTime":"0","endTime":"0","summary":"Detailed launch readiness for relutrigine and ulixacaltamide, with PDUFA target action dates of December 27, 2026 and January 29, 2027 Shared updated long-term efficacy data for both relutrigine and u","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/11/12/3402276/0/en/praxis-precision-medicines-details-launch-readiness-for-relutrigine-and-ulixacaltamide-and-outlines-expanded-pipeline-in-preparation-to-be-the-preeminent-cns-biotech-at-investor-da.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7062","BK4183","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","XBI","ASO.AU","BK4561","BK4139","032820.KR","TPZ","IE0009354923.USD","BK4585","AMLP","PAC.AU","USAI","IE00B2B36J28.USD","IE00BJT1NW94.SGD","UMI","IE0002141913.USD","BK9077","ODD","IE00B4R5TH58.HKD","BK4174","MDST","CNS","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4590","BK7095","BK4144","TNGY","ET","PRAX","BK4200","BK4135","AMZA","EIPI","IE00BFTCPJ56.SGD","PAC","MLPA","ASO","IBRN","BK4588","ENFR","BK4581","EMLP","EIPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683510597","title":"Solesence's Q3 Revenue Rises 38% to Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=2683510597","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683510597?lang=en_us&edition=fundamental","pubTime":"2026-11-13 05:24","pubTimestamp":1794518694,"startTime":"0","endTime":"0","summary":"Solesence's Q3 revenue rises 38% to record highOverviewUS health care solutions firm's Q3 revenue rose 38% yr/yr to record $20.2 mlnNet income reached $3.7 mln, highest in company historyGross margin ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T1G4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD","IE0009354923.USD","MYO","SLSN","BK4183","BK4082","HBIO","BK4109","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683751773","title":"Press Release: Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2683751773","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683751773?lang=en_us&edition=fundamental","pubTime":"2026-11-13 05:15","pubTimestamp":1794518100,"startTime":"0","endTime":"0","summary":"-- Following positive NEXICART-2 clinical update, commercial launch preparation continues with commercial site activation activities, strengthened team, and provider and payer engagement ---- Interim NEXICART-2 clinical trial results selected for oral presentation at ASH 2026 --LOS ANGELES, Nov. 12, 2026  -- Immix Biopharma, Inc. , a global leader in AL amyloidosis, today reported an update on corporate progress and financial results for the quarter ended September 30, 2026.Recent NXC-201 Progress--  Positive clinical data: 89% complete response rate. was reported across all 45 NEXICART-2 patients, with. --  Immix continues to advance its AL Amyloidosis launch","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMX","BK4588","LU1169590202.USD","ASH","LU2065732104.USD","LABU","BK7057","ASH.AU","BK4585","LU2463526074.USD","LU1169589451.USD","PRGS","BK4183","BK4572","BK4097","BK4232","IE0009354923.USD","AL","IE00B19Z6F94.USD","R","ODD","BK4104","BK4139","BK4109","IE0034390439.USD","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683663511","title":"Oddity Tech Price Target Raised to $15.00/Share from $12.00 by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2683663511","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683663511?lang=en_us&edition=fundamental","pubTime":"2026-11-13 02:52","pubTimestamp":1794509520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ODD/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4183","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683051651","title":"These Analysts Boost Their Forecasts On Oddity Tech After Upbeat Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2683051651","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683051651?lang=en_us&edition=fundamental","pubTime":"2026-11-13 01:18","pubTimestamp":1794503902,"startTime":"0","endTime":"0","summary":"Oddity beat Q3 earnings and sales estimates, raised FY2026 sales guidance, but shares fell 10.3% as analysts modestly lifted price targets.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/11/63207036/these-analysts-boost-their-forecasts-on-oddity-tech-after-upbeat-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD","BK4183","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682251884","title":"Intellia Therapeutics Presents Additional Positive Clinical and Patient-Reported Data for Lonvoguran Ziclumeran (lonvo-z) at ACAAI 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2682251884","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682251884?lang=en_us&edition=fundamental","pubTime":"2026-11-12 23:00","pubTimestamp":1794495600,"startTime":"0","endTime":"0","summary":"Among patients previously on long-term prophylaxis (LTP) in HAELO Phase 3 trial, monthly attack rate decreased by 81% following lonvo-z dosing compared with prior LTP100% of patients receiving 50 mg o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/11/12/3401802/0/en/intellia-therapeutics-presents-additional-positive-clinical-and-patient-reported-data-for-lonvoguran-ziclumeran-lonvo-z-at-acaai-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLA.AU","IE00B64QTZ34.USD","BK4139","032820.KR","BK4585","LU1861559042.SGD","BK9077","ODD","LU0106261612.USD","BK4588","LU1169589451.USD","BK7096","HAE","LU0205193047.USD","LU1861558580.USD","BK4198","IE0034390439.USD","BK4183","IE00BLDYK493.USD","LTP.AU","LU1169590202.USD","LU0012050646.USD","BK4556","NTLA","IE0009354923.USD","IE00B19Z6F94.USD","LU0205194284.USD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682590840","title":"Oddity price target raised to $11 from $10 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2682590840","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682590840?lang=en_us&edition=fundamental","pubTime":"2026-11-12 22:36","pubTimestamp":1794494191,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Oddity (ODD) to $11 from $10 and keeps an Underperform rating on the shares. Published first on TheFly – the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oddity-price-target-raised-to-11-from-10-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oddity-price-target-raised-to-11-from-10-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","ODD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682564483","title":"Oddity price target raised to $15 from $12 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2682564483","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682564483?lang=en_us&edition=fundamental","pubTime":"2026-11-12 18:40","pubTimestamp":1794480020,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Oddity (ODD) to $15 from $12 and keeps an Underweight rating on the shares. While Oddity announced the 2...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oddity-price-target-raised-to-15-from-12-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oddity-price-target-raised-to-15-from-12-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","IE0009354923.USD","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682958885","title":"Oddity Tech Ltd. Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2682958885","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682958885?lang=en_us&edition=fundamental","pubTime":"2026-11-11 22:31","pubTimestamp":1794407466,"startTime":"0","endTime":"0","summary":"ODDITY Tech Ltd. reports results for the quarter ended September 30 - Earnings SummaryODDITY Tech Ltd.ODD.OQreported quarterly adjusted earnings of 37 cents per share for the quarter ended September 3","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nL5N46S1KL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ODD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682309745","title":"Oddity Tech Q3 Revenue Falls 2% but Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2682309745","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682309745?lang=en_us&edition=fundamental","pubTime":"2026-11-11 20:13","pubTimestamp":1794399222,"startTime":"0","endTime":"0","summary":"Oddity Tech Q3 revenue falls 2% but beats estimatesOverviewUS beauty tech firm's Q3 revenue declined 2% yr/yr but beat analyst expectationsAdjusted EPS declined, but exceeded analyst expectationsCompa","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nL2N46S0GI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ODD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682097423","title":"Earnings Flash (ODD) Oddity Tech Posts Q3 Revenue $145M, vs. FactSet Est of $140.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2682097423","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682097423?lang=en_us&edition=fundamental","pubTime":"2026-11-11 20:13","pubTimestamp":1794399217,"startTime":"0","endTime":"0","summary":"Earnings Flash (ODD) Oddity Tech Posts Q3 Revenue $145M, vs. FactSet Est of $140.5M","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682091113","title":"Oddity Tech Q3 Net Income Falls 37% to USD 11.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2682091113","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682091113?lang=en_us&edition=fundamental","pubTime":"2026-11-11 20:04","pubTimestamp":1794398665,"startTime":"0","endTime":"0","summary":"Oddity Tech Q3 net income falls 37% to USD 11.2 millionOddity Tech’s third-quarter 2026 net income fell 37% year-over-year to $11.2 million, while net revenue declined to $144.98 million.SpoiledChild ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nNDL1VPr7S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD","LU0314104364.USD","LU2095319765.USD","SG9999014039.USD","IE00BQXX3C00.GBP","SG9999014005.SGD","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4588","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4183","IE0009354923.USD","BCDF","BK4112","IE00BKPKM429.USD","IE00BQXX3D17.EUR","BK4585","LU2210150020.SGD","SG9999014013.SGD","NDAQ","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682030991","title":"Oddity Tech Q3 Adjusted EPS USD 0.37 Vs. IBES Estimate USD 0.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2682030991","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682030991?lang=en_us&edition=fundamental","pubTime":"2026-11-11 20:01","pubTimestamp":1794398462,"startTime":"0","endTime":"0","summary":"BRIEF-ODDITY Tech Q3 Adjusted EPS USD 0.37 Vs. IBES Estimate USD 0.3Nov 11  - ODDITY Tech Q3 adjusted net income USD 18 million vs. IBES estimate USD 16.6 million.Q3 EPS USD 0.23Q3 adjusted EBITDA USD 22 million vs. IBES estimate USD 18.7 millionQ3 gross margin 67.4%Q3 revenue USD 145 million vs. IBES estimate USD 138.7 millionoutlook FY adjusted EBITDA USD 32-34 million vs. IBES estimate USD 31.1 million","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nPLXN5Q88Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4183","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682508309","title":"ODDITY Tech Q3 Adj. EPS $0.37 Beats $0.30 Estimate, Sales $144.981M Beat $138.683M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2682508309","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682508309?lang=en_us&edition=fundamental","pubTime":"2026-11-11 20:00","pubTimestamp":1794398433,"startTime":"0","endTime":"0","summary":"ODDITY Tech Q3 Adj. EPS $0.37 Beats $0.30 Estimate, Sales $144.981M Beat $138.683M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/ODD","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682830913","title":"Oddity Tech - Fy2026 Net Revenue Expected to Decrease 18.5% Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2682830913","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682830913?lang=en_us&edition=fundamental","pubTime":"2026-11-11 20:00","pubTimestamp":1794398402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nPLXN5Q88Q:10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ODD","IE0009354923.USD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682330993","title":"Oddity Tech Outlook Q4 Adjusted Ebitda USD 4-6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2682330993","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682330993?lang=en_us&edition=fundamental","pubTime":"2026-11-11 20:00","pubTimestamp":1794398402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nPLXN5Q88Q:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ODD","IE0009354923.USD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682309904","title":"Oddity Tech - Q4 2026 Net Revenue Expected to Decrease 10%-11% Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2682309904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682309904?lang=en_us&edition=fundamental","pubTime":"2026-11-11 20:00","pubTimestamp":1794398402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nPLXN5Q88Q:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ODD","IE0009354923.USD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682309581","title":"Oddity Tech Q3 Adjusted Net Income USD 18 Million VS. Ibes Estimate USD 16.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2682309581","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682309581?lang=en_us&edition=fundamental","pubTime":"2026-11-11 20:00","pubTimestamp":1794398402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nPLXN5Q88Q:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","ODD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682309539","title":"Oddity Tech Q3 Gross Margin 67.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682309539","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682309539?lang=en_us&edition=fundamental","pubTime":"2026-11-11 20:00","pubTimestamp":1794398402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nPLXN5Q88Q:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ODD","IE0009354923.USD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682930954","title":"Press Release: Oddity Tech Reports Third Quarter 2026 Results Ahead of Plan, Raises Full Year Net Revenue and Adjusted Ebitda Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2682930954","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682930954?lang=en_us&edition=fundamental","pubTime":"2026-11-11 20:00","pubTimestamp":1794398400,"startTime":"0","endTime":"0","summary":"-- Third quarter net revenue of $145 million, down approximately 2%. -- Third quarter net income of $11 million and third quarter adjusted net. investments of $561 million, and aggregate credit facilities of $350. million which remain undrawnNEW YORK, Nov. 11, 2026  -- ODDITY Tech Ltd.  today announced its financial results for the third quarter ended September 30, 2026.\"We made further progress stabilizing our business and delivered strong results for SpoiledChild and METHODIQ,\" said Oran Holtzman, ODDITY co-founder and CEO. \"We continue to work in close collaboration with our largest advertising partner to solve the IL MAKIAGE account dislocation and are hopeful we are on a path to normalization. Our goal is to return the company to growth and we are optimistic about the initiatives planned for 2027.\"ODDITY achieved key objectives during the third quarter, including:-- Net revenue and adjusted EBITDA results above our outlook for the third. quarter. SpoiledChild is on track to grow a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","ODD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://oddity.com","stockEarnings":[{"period":"1week","weight":-0.1264},{"period":"1month","weight":-0.1849},{"period":"3month","weight":0.3448},{"period":"6month","weight":0.3937},{"period":"1year","weight":-0.5648},{"period":"ytd","weight":-0.5612}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Oddity Tech Ltd. operates as a consumer tech company that builds and scales digital-first brands to disrupt beauty and wellness industries. The company serves consumers worldwide through its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. It owns IL MAKIAGE and SpoiledChild brands. The company was incorporated in 2013 and is headquartered in Tel Aviv, Israel with additional office in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.053143},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.207461},{"month":3,"riseRate":0.666667,"avgChangeRate":0.025113},{"month":4,"riseRate":0.666667,"avgChangeRate":0.079804},{"month":5,"riseRate":0.666667,"avgChangeRate":0.086142},{"month":6,"riseRate":1,"avgChangeRate":0.075724},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.034719},{"month":8,"riseRate":0.25,"avgChangeRate":-0.108719},{"month":9,"riseRate":0.75,"avgChangeRate":0.02737},{"month":10,"riseRate":0.25,"avgChangeRate":-0.065104},{"month":11,"riseRate":0.5,"avgChangeRate":0.078414},{"month":12,"riseRate":0.333333,"avgChangeRate":0.066185}],"exchange":"NASDAQ","name":"ODDITY Tech Ltd.","nameEN":"ODDITY Tech Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ODDITY Tech Ltd.(ODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ODDITY Tech Ltd.(ODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ODDITY Tech Ltd.,ODD,ODDITY Tech Ltd.股票,ODDITY Tech Ltd.股票老虎,ODDITY Tech Ltd.股票老虎国际,ODDITY Tech Ltd.行情,ODDITY Tech Ltd.股票行情,ODDITY Tech Ltd.股价,ODDITY Tech Ltd.股市,ODDITY Tech Ltd.股票价格,ODDITY Tech Ltd.股票交易,ODDITY Tech Ltd.股票购买,ODDITY Tech Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ODDITY Tech Ltd.(ODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ODDITY Tech Ltd.(ODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}